Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of DECIPHER LABS. For more details, see the DECIPHER LABS quarterly results and DECIPHER LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 6.1 |
No. of shares | m | 10.10 |
1 Week | % | -0.4 |
1 Month | % | 3.1 |
1 Year | % | -14.4 |
52 week H/L | Rs | 25.8/14.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DECIPHER LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 31 | 34 | 41 | 146 | 63 | |
Low | Rs | 17 | 16 | 18 | 27 | 14 | |
Sales per share (Unadj.) | Rs | 10.1 | 23.7 | 55.0 | 64.7 | 45.1 | |
Earnings per share (Unadj.) | Rs | 0.5 | 1.1 | 1.4 | 11.3 | -2.7 | |
Diluted earnings per share | Rs | 0.4 | 1.1 | 1.4 | 11.3 | -2.7 | |
Cash flow per share (Unadj.) | Rs | 0.5 | 1.6 | 2.2 | 12.1 | -2.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 3.2 | 12.4 | 13.6 | 23.9 | 23.0 | |
Adj. book value per share | Rs | 2.5 | 12.4 | 13.6 | 23.9 | 23.0 | |
Shares outstanding (eoy) | m | 8.00 | 10.10 | 10.10 | 10.10 | 10.10 | |
Price / Sales ratio | x | 2.4 | 1.1 | 0.5 | 1.3 | 0.9 | |
Avg P/E ratio | x | 47.9 | 23.1 | 21.3 | 7.7 | -14.5 | |
P/CF ratio (eoy) | x | 47.8 | 15.3 | 13.4 | 7.1 | -17.3 | |
Price / Book Value ratio | x | 7.7 | 2.0 | 2.2 | 3.6 | 1.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 194 | 254 | 298 | 872 | 389 | |
Total wages/salary | Rs m | 10 | 193 | 473 | 475 | 412 |
DECIPHER LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 81 | 240 | 556 | 653 | 456 | |
Other income | Rs m | 0 | 3 | 6 | 77 | 74 | |
Total revenues | Rs m | 81 | 243 | 562 | 730 | 529 | |
Gross profit | Rs m | 4 | 25 | 35 | 60 | -106 | |
Depreciation | Rs m | 0 | 6 | 8 | 9 | 4 | |
Interest | Rs m | 0 | 8 | 12 | 5 | 5 | |
Profit before tax | Rs m | 4 | 15 | 21 | 124 | -42 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 4 | 7 | 10 | -15 | |
Profit after tax | Rs m | 4 | 11 | 14 | 114 | -27 | |
Gross profit margin | % | 5.6 | 10.5 | 6.3 | 9.2 | -23.3 | |
Effective tax rate | % | 8.0 | 24.9 | 34.5 | 7.9 | 35.5 | |
Net profit margin | % | 5.0 | 4.6 | 2.5 | 17.4 | -5.9 |
DECIPHER LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 63 | 227 | 225 | 382 | 201 | |
Current liabilities | Rs m | 38 | 213 | 173 | 111 | 50 | |
Net working cap to sales | % | 31.0 | 5.6 | 9.4 | 41.5 | 33.2 | |
Current ratio | x | 1.7 | 1.1 | 1.3 | 3.4 | 4.1 | |
Inventory Days | Days | 1 | 117 | 77 | 5 | 30 | |
Debtors Days | Days | 1,566 | 2,224 | 766 | 715 | 789 | |
Net fixed assets | Rs m | 0 | 127 | 161 | 37 | 71 | |
Share capital | Rs m | 80 | 101 | 101 | 101 | 101 | |
"Free" reserves | Rs m | -55 | 25 | 36 | 141 | 131 | |
Net worth | Rs m | 25 | 126 | 137 | 242 | 232 | |
Long term debt | Rs m | 0 | 0 | 67 | 67 | 0 | |
Total assets | Rs m | 63 | 353 | 387 | 419 | 272 | |
Interest coverage | x | 74.5 | 2.9 | 2.8 | 26.5 | -7.6 | |
Debt to equity ratio | x | 0 | 0 | 0.5 | 0.3 | 0 | |
Sales to assets ratio | x | 1.3 | 0.7 | 1.4 | 1.6 | 1.7 | |
Return on assets | % | 6.5 | 5.3 | 6.7 | 28.3 | -8.1 | |
Return on equity | % | 16.0 | 8.8 | 10.2 | 47.1 | -11.6 | |
Return on capital | % | 17.7 | 17.8 | 16.2 | 41.6 | -15.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
DECIPHER LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2 | -152 | 18 | 83 | -16 | |
From Investments | Rs m | -0 | -1 | -3 | -5 | -43 | |
From Financial Activity | Rs m | 1 | 164 | 40 | 13 | -22 | |
Net Cashflow | Rs m | 3 | 12 | 55 | 84 | -80 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
COMP SEC: Kumar Raghavan | YEAR OF INC: 1986 | BSE CODE: 524752 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare DECIPHER LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.